Abstract:Abstract: Objective?To observe the efficacy of nasal endoscopic surgery on chronic rhino-sinusitis and the level of serum markers.?Methods?172 cases diagnosed as chronic rhino-sinusitis were divided into observation group (86 cases) and a contrast group (86 cases) randomly. The observation group were treated by nasal endoscopic surgery, the control group were treated by nonoperative treatment. The effects of treatment of nasal endoscopic surgery were measured by VAS scores and Lund-Kennedy endoscopic scores. The serum levels of IL-5, IL-12, IL-17, TNF-α, HMGB1 and HCGP-39 were measured by ELISA method.?Results?The difference was not statistically significant (P?>?0.05) between the two groups of VAS scores and Lund-Kennedy endoscopic scores before beginning therapy. The difference was statistically significant (P?0.05) between the two groups of VAS scores and Lund-Kennedy endoscopic scores after therapy. The VAS scores and Lund-Kennedy endoscopic scores after therapy in observation was lower than that in control group. The difference was not statistically significant (P?>?0.05) between the two groups of the levels of IL-5, IL-12, IL-17, TNF-α, HMGB1 and HCGP-39 before beginning therapy. The difference was statistically significant (P?0.05) between the two groups of the levels of IL-5, IL-12, IL-17, TNF-α, HMGB1 and HCGP-39 after therapy. The levels of IL-5, IL-12, IL-17, TNF-α, HMGB1 and HCGP-39 after therapy in observation was lower than that in control group.?Conclusions?Nasal endoscopic surgery is effective for chronic rhino-sinusitis, and can lower the levels of IL-5, IL-12, IL-17, TNF-α, HMGB1 and HCGP-39 in serum.